Skip to main content

Table 4 The effect of UFH for the thresholds: a paired t test

From: Which is the proper reference tissue for measuring the change in FDG PET metabolic volume of cardiac sarcoidosis before and after steroid therapy?

  

Pre-therapy

 

p value

During therapy

 

p value

Region

UFH (+)

(n = 30)

UFH (−)

(n = 8)

 

UFH (+)

(n = 27)

UFH (−)

(n = 11)

 

SUVmean + 3SD

Liver 1

3.5 ± 0.4

3.6 ± 0.5

0.29

3.9 ± 0.6

3.4 ± 0.5

0.03

SUVmax

Liver 2

3.5 ± 0.4

3.6 ± 0.4

0.76

4.0 ± 0.6

3.5 ± 0.5

0.03

DA

2.2 ± 0.3

2.1 ± 0.3

0.76

2.3 ± 0.3

2.1 ± 0.3

0.09

SUVmean

Liver 2

2.7 ± 0.3

2.8 ± 0.4

0.23

3.1 ± 0.5

2.7 ± 0.4

0.03

DA

1.9 ± 0.3

1.9 ± 0.3

0.83

2.0 ± 0.3

1.8 ± 0.3

0.1

SUVpeak

Liver 2

3.0 ± 0.4

3.1 ± 0.4

0.61

3.5 ± 0.6

3.1 ± 0.5

0.03

DA

2.0 ± 0.3

1.9 ± 0.3

0.51

2.0 ± 0.3

1.9 ± 0.3

0.06

  1. SD standard deviation, UFH unfractionated heparin, SUV standardized uptake value, Liver 1 SUV in the liver by semi-automated method, Liver 2 SUV in the liver by manual process, DA descending aorta